ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Developing antibiotics for children: There are no easy answers
The hunt for oral antibiotics: Beyond Lipinski’s Rule of Five
Economic modeling of the value of rapid diagnostics
Limits on measuring the impact of rapid antimicrobial susceptibility testing (AST)
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
IDSA White Paper on developing narrow-spectrum antimicrobials + editorial by G. Drusano
The 37,000-year view: Infections in Eurasia
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
De-risking vaccine development: Insights spanning decades of experience
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet








